Immune dysregulation and system pathology in COVID-19
M Jamal, HI Bangash, M Habiba, Y Lei, T Xie, J Sun… - Virulence, 2021 - Taylor & Francis
ABSTRACT The coronavirus disease 19 (COVID-19) caused by the novel coronavirus
known as SARS-CoV-2 has caused a global public health crisis. As of 7 January 2021 …
known as SARS-CoV-2 has caused a global public health crisis. As of 7 January 2021 …
COVID-19: in the eye of the cytokine storm
R De la Rica, M Borges, M Gonzalez-Freire - Frontiers in immunology, 2020 - frontiersin.org
The dysregulated release of cytokines has been identified as one of the key factors behind
poorer outcomes in COVID-19. This “cytokine storm” produces an excessive inflammatory …
poorer outcomes in COVID-19. This “cytokine storm” produces an excessive inflammatory …
Navigating the post-COVID-19 immunological era: understanding long COVID-19 and immune response
The COVID-19 pandemic has affected the world unprecedentedly, with both positive and
negative impacts. COVID-19 significantly impacted the immune system, and understanding …
negative impacts. COVID-19 significantly impacted the immune system, and understanding …
[PDF][PDF] Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes lethal
coronavirus disease (COVID-19). SARS-CoV-2 has been the chief source of threat to public …
coronavirus disease (COVID-19). SARS-CoV-2 has been the chief source of threat to public …
Implications of low-grade inflammation in SARS-CoV-2 immunopathology
A Suarez-Reyes, CA Villegas-Valverde - MEDICC review, 2021 - medigraphic.com
ABSTRACT INTRODUCTION Advanced age and chronic disease comorbidities are
indicators of poor prognosis in COVID-19 clinical progression. Fatal outcomes in patients …
indicators of poor prognosis in COVID-19 clinical progression. Fatal outcomes in patients …
Immune responses during COVID-19 infection
C Melenotte, A Silvin, AG Goubet, I Lahmar… - …, 2020 - Taylor & Francis
Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome CoV
(SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …
(SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …
Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm
To the Editor: Since the emergence of Coronavirus Disease 2019 (COVID-19) caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …
Immunomodulation as treatment for severe coronavirus disease 2019: a systematic review of current modalities and future directions
EA Meyerowitz, P Sen, SR Schoenfeld… - Clinical Infectious …, 2021 - academic.oup.com
In severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, viral load
peaks early and declines quickly after symptom onset. Severe coronavirus disease 2019 …
peaks early and declines quickly after symptom onset. Severe coronavirus disease 2019 …
Road map to understanding SARS-CoV-2 clinico-immunopathology and COVID-19 disease severity
SARS-CoV-2, a novel coronavirus, was first identified in Wuhan, China in December 2019.
The rapid spread of the virus worldwide prompted the World Health Organization (WHO) to …
The rapid spread of the virus worldwide prompted the World Health Organization (WHO) to …
The impact of pre-existing comorbidities and therapeutic interventions on COVID-19
LA Callender, M Curran, SM Bates… - Frontiers in …, 2020 - frontiersin.org
Evidence from the global outbreak of SARS-CoV-2 has clearly demonstrated that individuals
with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of …
with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of …